Health ❯ Healthcare ❯ Clinical Trials

Drug Development

Phase 3 Trials Combination Therapy Eli Lilly Targeted Therapy Phase III Trials Daraxonrasib Alzheimer's Treatments Oncology RAS Inhibitors Patient Outcomes

3 ARTICLES

last wk.

Moderna and Merck Report Positive Phase 3 Results for Personalized mRNA Melanoma Vaccine

An interim analysis showed improved recurrence-free and distant-metastasis-free survival with no new safety signals, and the companies plan to release full data and begin regulatory discussions.

5 ARTICLES

2w ago

EyePoint Stock Collapses After Duravyu Misses Phase 3 Primary Endpoint

3 ARTICLES

3w ago

FDA Authorizes Intermountain to Give Investigational KRAS Drug to Pancreatic Cancer Patients

6 ARTICLES

3w ago

AbCellera’s Menopause Antibody Hits Phase 2 Goals

6 ARTICLES

last mo.

Novo Nordisk’s Ziltivekimab Lowers Inflammation but Fails to Reduce Major Heart Events

7 ARTICLES

last mo.

Copper Compound Restores Brain Clearance Pump and Cuts Alzheimer’s Proteins in Mice

3 ARTICLES

2mo ago

Sanofi Stops MOBILIZE Phase 3 Trial of Riliprubart in CIDP After Futility Finding

4 ARTICLES

3mo ago

Roche Stops Phase 3 for Acmopatide After Positive Phase 2 in Type 1 Diabetes

3 ARTICLES

3mo ago

U.S. Biotech Reports Major Survival Gain in Pancreatic Cancer as Hiroshima Plans 2028 Trial for MicroRNA Mesothelioma Drug

11 ARTICLES

3mo ago

Abivax Drug Shows Breakthrough Ulcerative Colitis Results as Shares Plunge After Cancer Cases

12 ARTICLES

3mo ago

Daraxonrasib Nearly Doubles Median Survival in Previously Treated Metastatic Pancreatic Cancer

4 ARTICLES

3mo ago

Experimental ERAP1 Inhibitor Plus Immunotherapy Shrinks Tumours in Early Trial

Drug Development

Moderna and Merck Report Positive Phase 3 Results for Personalized mRNA Melanoma Vaccine

EyePoint Stock Collapses After Duravyu Misses Phase 3 Primary Endpoint

FDA Authorizes Intermountain to Give Investigational KRAS Drug to Pancreatic Cancer Patients

AbCellera’s Menopause Antibody Hits Phase 2 Goals

Novo Nordisk’s Ziltivekimab Lowers Inflammation but Fails to Reduce Major Heart Events

AstraZeneca Beats Q2 Estimates and Reaffirms 2026 Guidance

Anvisa Says Retatrutida Is Unapproved as Illegal Versions Spread

FDA Clears Wearable Injector Form of Sanofi’s Multiple Myeloma Drug

SII and DNDi to Run International Phase III Trial of Dengue Monoclonal Antibody

EMA Opens Rolling Review as U.S. Hospitals Start Early Access to Daraxonrasib

Never miss stories about

Drug Development

Moderna Repositions as Broad mRNA Company After Investor Day Rally

Study Maps How Leukemia Enters Lungs and Identifies Drug Targets

Biogen to Buy RayThera for Up to $1 Billion

Copper Compound Restores Brain Clearance Pump and Cuts Alzheimer’s Proteins in Mice

Sanofi Stops MOBILIZE Phase 3 Trial of Riliprubart in CIDP After Futility Finding

Roche Stops Phase 3 for Acmopatide After Positive Phase 2 in Type 1 Diabetes

U.S. Biotech Reports Major Survival Gain in Pancreatic Cancer as Hiroshima Plans 2028 Trial for MicroRNA Mesothelioma Drug

Abivax Drug Shows Breakthrough Ulcerative Colitis Results as Shares Plunge After Cancer Cases

Daraxonrasib Nearly Doubles Median Survival in Previously Treated Metastatic Pancreatic Cancer

Experimental ERAP1 Inhibitor Plus Immunotherapy Shrinks Tumours in Early Trial

Never miss stories about

Drug Development